XML 80 R52.htm IDEA: XBRL DOCUMENT v3.22.4
REVENUE (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Sales Commission Amortization Period Minimum 1 year    
Percent of Revenue Contributed 100.00% 100.00% 100.00%
Sales Commission Amortization Period Maximum 5 years    
Revenues $ 14,876,800,000 $ 16,120,900,000 $ 13,978,500,000
Percent of Domestic Revenue 77.50% 77.90% 80.10%
Amortization of Deferred Sales Commissions $ 33,900,000 $ 27,500,000 $ 23,200,000
Accrued Sales Commission 38,200,000 36,200,000  
Capitalized Contract Cost, Net 15,000,000.0 14,400,000  
Amount of Deferred Costs Related to Long-term Contracts 53,200,000 50,600,000  
Capitalized Contract Cost, Amortization 12,400,000 14,200,000 10,100,000
Contract with Customer, Asset, before Allowance for Credit Loss 805,900,000 730,800,000  
Allowance for Credit Loss, Receivable, Other, Current (10,500,000) (14,000,000.0)  
Contract with Customer, Asset, after Allowance for Credit Loss, Current 795,400,000 716,800,000  
Contract with Customer, Liability 582,100,000 558,500,000  
Deferred Revenue, Revenue Recognized 330,500,000 319,400,000 262,600,000
Revenue, Remaining Performance Obligation, Amount $ 5,122,100,000    
Percent of remaining performance obligations recognized as revenue in next year 30.00%    
Long Term Contracts Duration Minimum 1 year    
Long Term Contracts Duration Maximum 8 years    
Contract with Customer, Performance Obligation Satisfied in Previous Period $ 73,000,000.0 69,800,000  
Accounts Receivable, Allowance for Credit Loss 43,500,000 21,500,000 22,100,000
Unbilled Services, Allowance for Credit Loss 10,500,000 13,900,000 11,300,000
Note Receivable, Allowance for Credit Loss 700,000 700,000 5,700,000
Allowance for Credit Loss 54,700,000 36,100,000 39,100,000
Accounts Receivable, Credit Loss Expense (Reversal) 15,100,000 3,800,000  
Unbilled Services, Credit Loss Expense (Reversal) 0 2,700,000  
Note Receivable, Credit Loss Expense (Reversal) 0 (5,000,000.0)  
Credit Loss Expense (Reversal) 15,100,000 1,500,000  
Allowance for Credit Loss, Write Off 3,500,000 4,500,000  
Geographic Distribution, Domestic [Member]      
Disaggregation of Revenue [Line Items]      
Revenues $ 11,530,500,000 $ 12,566,200,000 $ 11,192,300,000
Medicare and Medicaid [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 6.00% 7.00% 7.00%
Europe [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 13.00% 13.00% 11.00%
North America      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 80.00% 81.00% 82.00%
Other countries [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 7.00% 6.00% 7.00%
Covance Drug Development [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed   36.00%  
Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 39.00% 36.00% 35.00%
Covance Drug Development [Member] | Europe [Member] | Biopharmaceutical and medical device companies [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 13.00% 13.00% 11.00%
Covance Drug Development [Member] | North America | Biopharmaceutical and medical device companies [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 19.00% 17.00% 17.00%
Covance Drug Development [Member] | Other countries [Member] | Biopharmaceutical and medical device companies [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 7.00% 6.00% 7.00%
LabCorp Diagnostics [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 61.00% 64.00% 65.00%
LabCorp Diagnostics [Member] | Third party [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 31.00% 34.00% 32.00%
LabCorp Diagnostics [Member] | Self-Pay [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 6.00% 6.00% 6.00%
LabCorp Diagnostics [Member] | Client [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 18.00% 17.00% 20.00%
LabCorp Diagnostics [Member] | Europe [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | Europe [Member] | Third party [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | Europe [Member] | Medicare and Medicaid [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | Europe [Member] | Self-Pay [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | Europe [Member] | Client [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | North America      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 61.00% 64.00% 65.00%
LabCorp Diagnostics [Member] | North America | Third party [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 31.00% 34.00% 32.00%
LabCorp Diagnostics [Member] | North America | Medicare and Medicaid [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 6.00% 7.00% 7.00%
LabCorp Diagnostics [Member] | North America | Self-Pay [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 6.00% 6.00% 6.00%
LabCorp Diagnostics [Member] | North America | Client [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 18.00% 17.00% 20.00%
LabCorp Diagnostics [Member] | Other countries [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | Other countries [Member] | Third party [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
LabCorp Diagnostics [Member] | Other countries [Member] | Medicare and Medicaid [Member]      
Disaggregation of Revenue [Line Items]      
Percent of Revenue Contributed 0.00% 0.00% 0.00%
Maximum [Member]      
Disaggregation of Revenue [Line Items]      
Capitalized Contract Cost, Amortization Period 5 years    
Minimum [Member]      
Disaggregation of Revenue [Line Items]      
Capitalized Contract Cost, Amortization Period 2 years    
Accounts Receivable [Member]      
Allowance for Credit Loss, Write Off $ 6,900,000 $ 4,400,000  
Unbilled Contracts Receivable      
Allowance for Credit Loss, Write Off 3,400,000 100,000  
Notes Receivable      
Allowance for Credit Loss, Write Off $ 0 $ 0